We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-4.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.5B
AUM Growth
-$1.66B
Cap. Flow
-$1.45B
Cap. Flow %
-11.6%
Top 10 Hldgs %
32.88%
Holding
1,206
New
194
Increased
593
Reduced
261
Closed
41

Sector Composition

Rank Sector Weight
1 Real Estate 73.13%
2 Industrials 4.58%
3 Technology 4.24%
4 Financials 3.1%
5 Healthcare 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRWD icon
1001
Ironwood Pharmaceuticals
IRWD
$644M
$12K ﹤0.01%
+893
New +$11.1K
LAND
1002
Gladstone Land Corp
LAND
$367M
$12K ﹤0.01%
1,000
GBT
1003
DELISTED
Global Blood Therapeutics, Inc.
GBT
$12K ﹤0.01%
+241
New +$13.4K
IMMU
1004
DELISTED
Immunomedics Inc
IMMU
$12K ﹤0.01%
+840
New +$13.7K
WUBA
1005
DELISTED
58.com Inc
WUBA
$12K ﹤0.01%
+150
New +$11.8K
PTLA
1006
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$12K ﹤0.01%
+361
New +$15.8K
CBPO
1007
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$12K ﹤0.01%
+153
New +$12.4K
MYGN icon
1008
Myriad Genetics
MYGN
$515M
$11K ﹤0.01%
+383
New +$13K
NVCR icon
1009
NovoCure
NVCR
$1.97B
$11K ﹤0.01%
+494
New +$10.6K
AERI
1010
DELISTED
Aerie Pharmaceuticals
AERI
$11K ﹤0.01%
+203
New +$11.4K
ESPR
1011
DELISTED
Esperion Therapeutics
ESPR
$10K ﹤0.01%
+145
New +$10.6K
INSM icon
1012
Insmed
INSM
$22.7B
$10K ﹤0.01%
+423
New +$11.1K
INVA icon
1013
Innoviva
INVA
$1.57B
$10K ﹤0.01%
+597
New +$9.21K
OPK icon
1014
Opko Health
OPK
$936M
$10K ﹤0.01%
+3,091
New +$12.4K
ITCL
1015
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$10K ﹤0.01%
700
XLRN
1016
DELISTED
Acceleron Pharma
XLRN
$10K ﹤0.01%
+250
New +$10.6K
MYOK
1017
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$10K ﹤0.01%
+198
New +$10.3K
NRG icon
1018
NRG Energy
NRG
$28.8B
$9K ﹤0.01%
310
+104
+50% +$2.88K
RGEN icon
1019
Repligen
RGEN
$7.39B
$9K ﹤0.01%
+241
New +$8.47K
SGMO
1020
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$9K ﹤0.01%
+467
New +$9.98K
ICPT
1021
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$9K ﹤0.01%
+139
New +$8.38K
SPPI
1022
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$9K ﹤0.01%
+556
New +$11K
RDUS
1023
DELISTED
Radius Health, Inc.
RDUS
$9K ﹤0.01%
+246
New +$8.89K
ARNA
1024
DELISTED
Arena Pharmaceuticals Inc
ARNA
$9K ﹤0.01%
+217
New +$8.44K
AIMT
1025
DELISTED
Aimmune Therapeutics
AIMT
$9K ﹤0.01%
+281
New +$9.89K

Similar funds

Daiwa Securities Group's Q1 2018 Portfolio in Review

As of Q1 2018, Daiwa Securities Group held 1,206 positions worth $12.5B, down 12% from $14.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $1.45B in Q1 2018, closing 41 positions and reducing 261 holdings. Its most notable exit was Anthem, Inc., an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 77% a quarter earlier, followed by Industrials and Technology.

Against the trend, Daiwa Securities Group opened a new position in Supernus Pharmaceuticals worth $3.16M.

  • Daiwa Securities Group's largest Q1 2018 buy was Supernus Pharmaceuticals: 68,983 shares worth $3.16M.
  • Daiwa Securities Group added most to Boston Properties in Q1 2018, an estimated $165M increase.
  • Daiwa Securities Group's biggest Q1 2018 reduction was Simon Property Group, cutting an estimated $275M.
  • Daiwa Securities Group fully exited Anthem, Inc. in Q1 2018, selling an estimated $25.2M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $12.5B portfolio in Q1 2018.
  • Daiwa Securities Group opened 194 new positions and closed 41 in Q1 2018.
  • Daiwa Securities Group's portfolio value fell 12% quarter-over-quarter to $12.5B.

Based on Daiwa Securities Group's 13F filing for Q1 2018, filed 2 May 2018.